| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | 0 |
Sells | $9,785,125 | 1 | 100 |
| Cormorant Asset Management, LP | Former 10% Owner | 0 | $0 | 1 | $9.79M | $-9.79M |
Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio includes 5-HT2 Receptors, which are serotonin agonists for epilepsy and neuropsychiatric disorders; and BMB-101, which has completed phase 1 trial for undisclosed seizure disorder and is in phase 2 clinical trials for the developmental and epileptic encephalopathies and absence epilepsies. The company also develops BMB-201 and BMB-202 for the treatment of …
Over the last 12 months, insiders at Bright Minds Biosciences Inc. have bought $0 and sold $9.79M worth of Bright Minds Biosciences Inc. stock.
On average, over the past 5 years, insiders at Bright Minds Biosciences Inc. have bought $3.62M and sold $9.79M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 184,331 shares for transaction amount of $4M was made by Cormorant Asset Management, LP (10 percent owner) on 2024‑11‑04.
| 2026-04-28 | Sale | Cormorant Asset Management, LP | Former 10% Owner | 109,331 1.4167% | $89.50 | $9.79M | -20.40% | |
| 2024-11-04 | Cormorant Asset Management, LP | 10 percent owner | 184,331 1.3083% | $21.70 | $4M | -28.71% | ||
| 2024-10-16 | Cormorant Asset Management, LP | 10 percent owner | 50,000 0.3836% | $23.46 | $1.17M | +25.14% | ||
| 2024-10-15 | Cormorant Asset Management, LP | 10 percent owner | 372,591 0.6743% | $5.53 | $2.06M | -6.46% |
| Cormorant Asset Management, LP | Former 10% Owner | 950000 9.6309% | $20.47M | 3 | 1 | <0.0001% |
$22,710,871 | 107 | 8.53% | $220.62M | |
$168,352,523 | 35 | 13.58% | $218.79M | |
$74,231,875 | 30 | 40.62% | $183.78M | |
$54,828,550 | 26 | -13.88% | $201.12M | |
$3,858,993 | 22 | -9.81% | $192.38M |
| Increased Positions | 44 | +67.69% | 1M | +23.78% |
| Decreased Positions | 28 | -43.08% | 961,395 | -15.76% |
| New Positions | 17 | New | 868,185 | New |
| Sold Out Positions | 8 | Sold Out | 183,026 | Sold Out |
| Total Postitions | 81 | +24.62% | 7M | +8.01% |
| Janus Henderson Group Plc | $95,617.00 | 14.32% | 1.15M | 0 | 0% | 2025-09-30 |
| Cormorant Asset Management, Lp | $88,412.00 | 13.24% | 1.06M | 0 | 0% | 2025-09-30 |
| Vivo Capital, Llc | $41,865.00 | 6.27% | 501,617 | +250,045 | +99.39% | 2025-09-30 |
| Commodore Capital Lp | $41,730.00 | 6.25% | 500,000 | 0 | 0% | 2025-09-30 |
| Perceptive Advisors Llc | $37,498.00 | 5.62% | 449,290 | +28,600 | +6.8% | 2025-09-30 |
| Adage Capital Partners Gp, L.L.C. | $33,029.00 | 4.95% | 395,743 | +195,743 | +97.87% | 2025-09-30 |
| Braidwell Lp | $25,346.00 | 3.8% | 303,685 | +303,685 | New | 2025-09-30 |
| Blackrock, Inc. | $19,539.00 | 2.93% | 234,118 | +24,441 | +11.66% | 2025-09-30 |
| Morgan Stanley | $16,097.00 | 2.41% | 192,866 | +30,797 | +19% | 2025-09-30 |
| Sio Capital Management, Llc | $15,921.00 | 2.38% | 190,764 | -321,574 | -62.77% | 2025-09-30 |